Compare AVTX & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | BRT |
|---|---|---|
| Founded | 2011 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.4M | 269.9M |
| IPO Year | 2015 | 1994 |
| Metric | AVTX | BRT |
|---|---|---|
| Price | $17.76 | $15.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $40.57 | $19.75 |
| AVG Volume (30 Days) | ★ 1.5M | 27.9K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 7.03% |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $27,813,137.00 | ★ $97,028,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $5.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2312.27 | 1.46 |
| 52 Week Low | $4.73 | $13.18 |
| 52 Week High | $24.27 | $16.69 |
| Indicator | AVTX | BRT |
|---|---|---|
| Relative Strength Index (RSI) | 64.69 | 65.35 |
| Support Level | $13.13 | $14.23 |
| Resistance Level | $19.06 | $15.97 |
| Average True Range (ATR) | 1.06 | 0.35 |
| MACD | 0.55 | 0.02 |
| Stochastic Oscillator | 92.22 | 94.69 |
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.